Polycomb chromobox 4 enhances migration and pulmonary metastasis of hepatocellular carcinoma cell line MHCC97L

Science China Life Sciences

Volumn 57, Issue 6, 2014, Pages 610-617

  Mei, Zhu ^a   Jiao, HuiKe ^b   Wang, Wei ^a   Li, Jie ^a   Chen, GuoQiang ^a,b   Xu, Ying ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

hepatocellular carcinoma; metastasis; polycomb chromobox 4; vascular endothelial growth factor

Indexed keywords

MUS MUSCULUS;

CBX4 PROTEIN, HUMAN; POLYCOMB GROUP PROTEIN; UBIQUITIN PROTEIN LIGASE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL CYCLE CHECKPOINT; CELL MOTION; CELL PROLIFERATION; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; LUNG TUMOR; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SECONDARY; TUMOR CELL LINE; VASCULARIZATION; XENOGRAFT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HETEROGRAFTS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; POLYCOMB-GROUP PROTEINS; UBIQUITIN-PROTEIN LIGASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84901978546     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-014-4663-9     Document Type: Article

References (31)

1. Schwartz YB, Pirrotta V. Polycomb silencing mechanisms and the management of genomic programmes. Nat Rev Genet, 2007, 8: 9-22.
2. Morey L, Helin K. Polycomb group protein-mediated repression of transcription. Trends Biochem Sci, 2010, 35: 323-332.
3. Di Croce L, Helin K. Transcriptional regulation by polycomb group proteins. Nat Struct Mol Biol, 2013, 20: 1147-1155.
4. Su Y, Deng B, Xi R. Polycomb group genes in stem cell self-renewal: a double-edged sword. Epigenetics, 2011, 6: 16-19.
5. Levine SS, King IF, Kingston RE. Division of labor in polycomb group repression. Trends Biochem Sci, 2004, 29: 478-485.
6. Au SL, Ng IO, Wong CM. Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins. Front Med, 2013, 7: 231-241.
7. Radulovic V, de Haan G, Klauke K. Polycomb-group proteins in hematopoietic stem cell regulation and hematopoietic neoplasms. Leukemia, 2013, 27: 523-533.
8. Richly H, Aloia L, Di Croce L. Roles of the polycomb group proteins in stem cells and cancer. Cell Death Dis, 2011, 2: e204.
9. Wotton D, Merrill JC. Pc2 and sumoylation. Biochem Soc Trans, 2007, 35: 1401-1404.
10. Kagey MH, Melhuish TA, Wotton D. The polycomb protein Pc2 is a SUMO E3. Cell, 2003, 113: 127-137.
11. Long J, Zuo D, Park M. Pc2-mediated sumoylation of Smad-interacting protein 1 attenuates transcriptional repression of E-cadherin. J Biol Chem, 2005, 280: 35477-35489.
12. Li B, Zhou J, Liu P, Hu J, Jin H, Shimono Y, Takahashi M, Xu G. Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a. Biochem J, 2007, 405: 369-378.
13. Klein UR, Nigg EA. SUMO-dependent regulation of centrin-2. J Cell Sci, 2009, 122: 3312-3321.
14. Roscic A, Moller A, Calzado MA, Renner F, Wimmer VC, Gresko E, Ludi KS, Schmitz ML. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol Cell, 2006, 24: 77-89.
15. Fischle W, Wang Y, Jacobs SA, Kim Y, Allis CD, Khorasanizadeh S. Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. Genes Dev, 2003, 17: 1870-1881.
16. Merrill JC, Melhuish TA, Kagey MH, Yang SH, Sharrocks AD, Wotton D. A role for non-covalent SUMO interaction motifs in Pc2/Cbx4 E3 activity. PLoS ONE, 2010, 5: e8794.
17. Li J, Xu Y, Long XD, Wang W, Jiao HK, Mei Z, Yin QQ, Ma LN, Zhou AW, Wang LS, Yao M, Xia Q, Chen GQ. Cbx4 governs HIF-1alpha to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity. Cancer Cell, 2014, 25: 118-131.
18. Li J, Xu Y, Jiao HK, Wang W, Mei Z, Chen GQ. Regulation of hypoxia inducible factor-1alpha by SUMOylation and its signific-ances in cancers. Sci China Life Sci, 2014, in press.
19. Cui JF, Liu YK, Zhang LJ, Shen HL, Song HY, Dai Z, Yu YL, Zhang Y, Sun RX, Chen J, Tang ZY, Yang PY. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro. Proteomics, 2006, 6: 5953-5961.
20. Goel HL, Mercurio AM. VEGF targets the tumour cell. Nat Rev Cancer, 2013, 13: 871-882.
21. Roberts E, Cossigny DA, Quan GM. The role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton. Prostate Cancer, 2013, 2013: 418340.
22. Lin S, Hoffmann K, Schemmer P. Treatment of hepatocellular carcinoma: a systematic review. Liver Cancer, 2012, 1: 144-158.
23. Pang R, Poon RT. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett, 2006, 242: 151-167.
24. Zhu AX, Duda DG, Sahani DV, Jain RK. HCC and angiogenesis: possible targets and future directions. Nat Rev Clin Oncol, 2011, 8: 292-301.
25. Fang P, Hu JH, Cheng ZG, Liu ZF, Wang JL, Jiao SC. Efficacy and safety of bevacizumab for the treatment of advanced hepatocellular carcinoma: a systematic review of phase II trials. PLoS ONE, 2012, 7: e49717.
26. Di Marco V, De Vita F, Koskinas J, Semela D, Toniutto P, Verslype C. Sorafenib: from literature to clinical practice. Ann Oncol, 2013, 24(Suppl 2): II30-37.
27. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene, 2010, 29: 625-634.
28. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med, 2003, 9: 677-684.
29. Liu B, Liu YF, Du YR, Mardaryev AN, Yang W, Chen H, Xu ZM, Xu CQ, Zhang XR, Botchkarev VA, Zhang Y, Xu GL. Cbx4 regulates the proliferation of thymic epithelial cells and thymus function. Development, 2013, 140: 780-788.
30. Luis NM, Morey L, Mejetta S, Pascual G, Janich P, Kuebler B, Cozutto L, Roma G, Nascimento E, Frye M, Di Croce L, Benitah SA. Regulation of human epidermal stem cell proliferation and senescence requires polycomb-dependent and -independent functions of Cbx4. Cell Stem Cell, 2011, 9: 233-246.
31. Wang B, Tang J, Liao D, Wang G, Zhang M, Sang Y, Cao J, Wu Y, Zhang R, Li S, Ding W, Zhang G, Kang T. Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma. Ann Surg Oncol, 2013, 20(Suppl 3): S684-692.